A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
1 other identifier
observational
120
1 country
7
Brief Summary
The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2015
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 5, 2015
CompletedFirst Posted
Study publicly available on registry
August 7, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedJanuary 19, 2024
January 1, 2024
2.6 years
August 5, 2015
January 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion of Surveys
3 years
Study Arms (3)
Remote cancer genetic services by videoconference
Remote cancer genetic services by telephone
Usual Care
Interventions
Baseline and follow up survey
Baseline and follow up surveys
Baseline and follow up surveys
Eligibility Criteria
Candidate for genetic testing for BRCA or colon cancer related genes
You may qualify if:
- Eligible participants will include adult men and women (aged 18 and older) who can understand and communicate in English
- meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian or colorectal cancers
- have insurance coverage for genetic testing.
You may not qualify if:
- Under 18 years old - professional guidelines do not recommend genetic testing for cancer risk in minors.
- Does not speak English.
- Does not have insurance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Union Hospital
Elkton, Maryland, 21921, United States
Cape Regional Medical Center
Cape May Court House, New Jersey, 08210, United States
Kennedy Health
Sewell, New Jersey, 08080, United States
Shore Cancer Center
Somers Point, New Jersey, 08244, United States
Gettysburg Cancer Center
Gettysburg, Pennsylvania, 17325, United States
Drexel Cancer Care at Hahnemann
Philadelphia, Pennsylvania, 19102, United States
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angela Bradbury, MD
Abramson Cancer Center at Penn Medicine
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2015
First Posted
August 7, 2015
Study Start
August 1, 2015
Primary Completion
March 1, 2018
Study Completion
November 1, 2019
Last Updated
January 19, 2024
Record last verified: 2024-01